Cramer says ‘I don’t trust this market’ yet, given Russia-Ukraine, Fed rate hike uncertainties

Investing News

Jim Cramer
Scott Mlyn | CNBC

CNBC’s Jim Cramer said Tuesday the stock market may have “another couple days of this uncertainty,” until it becomes clear whether Russia will invade Ukraine or whether Moscow will stop with recognizing the independence of Luhansk and Donetsk, two breakaway regions there.

“The market needs to get a little more oversold because it’s not just Russia, it’s the Fed. So we just got to tread carefully,” the “Mad Money” host said.

“I don’t trust this market because every time that we think something good is going to happen, Putin pulls the rug out from under us. I don’t know why this time will be different,” Cramer said on “Squawk Box,” ahead of Tuesday’s open on Wall Street.

As Cramer was speaking, U.S. stock futures were way off overnight lows as world leaders started to apply more pressure on Russian President Vladimir Putin economically to halt his aggressions toward Ukraine.

  • The U.K. on Tuesday announced targeted sanctions against five Russian banks and three wealthy individuals.
  • One day after a rare U.N. Security Council emergency meeting, the U.S. expects to announce more sanctions targeting Russia on Tuesday.
  • Germany said Tuesday it’ll halt certification of the Nord Stream 2 pipeline designed to bring natural gas from Russia directly to Europe.

Stocks fell on Tuesday, and the Dow Jones Industrial Average slid about 300 points shortly after the open.

Cramer said he thinks Putin will do what he wants to do and won’t be swayed by punitive economic actions: “I think they’re bee stings.”

Give that backdrop, Cramer wasn’t prepared to yet to give the all clear on the market. “It’s foggy,” he said of the Russia crisis and how aggressive the Federal Reserve might be in fighting inflation.

The market expects seven Fed interest rate increases in this year, starting next month.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Articles You May Like

5 More Trump Stocks to Trade
Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook
Cathie Wood says her ‘volatile’ ARK Innovation fund shouldn’t be a ‘huge slice of any portfolio’
Activist ValueAct is poised to trim fat and help boost profits at Meta Platforms. Here’s how
Snowflake’s stock flies higher as software company’s outlook impresses